Skip to main content

Want a detailed portfolio tracker?

Rezolute (RZLT) P/E (2014 - 2026)

Rezolute (RZLT) P/E from May 1, 2014 to Jul 21, 2026. The TTM Rezolute (RZLT) P/E is -3.48. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Rezolute (RZLT)

YearP/EChange
2026-3.48+137.00%
2025-1.47-58.18%
2024-3.52+443.19%
2023-0.65-35.05%
2022-1.00-38.80%
2021-1.63-69.79%
2020-5.39-45.66%
2019-9.92+27.78%
2018-7.76-89.83%
2017-76.33-11.50%
2016-86.24-33.60%
2015-129.89+48.44%
2014-87.51N/A

Comparison Rezolute (RZLT) P/E with competitors

Rezolute (RZLT) P/E is -3.48.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.12%
ENLVEnlivex Ltd0.07-102.15%
FGENFibroGen Inc0.24-106.89%
CHRSCoherus Biosciences Inc0.85-124.35%
FBIOFortress Biotech Inc0.95-127.24%
ORMPOramed Pharmaceuticals Inc1.50-143.14%
AGENAgenus Inc3.01-186.37%
INVAInnoviva Inc3.15-190.52%
VXRTVaxart Inc3.55-201.87%
CRMDCorMedix Inc3.63-204.13%
CVACCureVac N.V.4.45-227.58%
GLPGGalapagos NV4.86-239.44%
SRPTSarepta Therapeutics Inc4.88-240.11%
ABEOAbeona Therapeutics Inc5.39-254.61%
ABUSArbutus Biopharma Corp5.60-260.59%
ZVRAZevra Therapeutics Inc5.89-268.96%
SPROSpero Therapeutics Inc6.23-278.75%
CGENCompugen Ltd6.31-281.20%
RIGLRigel Pharmaceuticals6.87-297.22%
SLXNSilexion Therapeutics Corp7.30-309.39%
OMEROmeros Corporation9.26-365.71%
AUPHAurinia Pharmaceuticals Inc9.58-375.08%
PLXProtalix BioTherapeutics Inc10.89-412.56%
ACADAcadia Pharmaceuticals Inc11.73-436.59%
TBPHTheravance Biopharma Inc12.26-451.91%
ADMAAdma Biologics Inc12.42-456.38%
HRMYHarmony Biosciences Holdings Inc13.82-496.62%
SABSSAB Biotherapeutics Inc14.14-505.69%
NAGENiagen Bioscience Inc14.82-525.26%
INCYIncyte Corp15.82-554.09%
REGNRegeneron Pharmaceuticals Inc15.86-555.07%
PBYIPuma Biotechnology Inc17.32-596.94%
CPRXCatalyst Pharmaceuticals Inc17.44-600.49%
EXELExelixis Inc17.54-603.32%
TGTXTG Therapeutics Inc18.97-644.30%
MDXGMimedx Group Inc20.55-689.83%
XOMAXOMA Royalty Corp22.87-756.49%
ARGXArgen X SE24.30-797.34%
CTMXCytomX Therapeutics Inc24.82-812.35%
XOMAOXOMA Royalty Corp25.34-827.38%
HALOHalozyme Therapeutics Inc25.62-835.39%
XOMAPXOMA Royalty Corp25.67-836.72%
VRTXVertex Pharmaceuticals Inc27.99-903.44%
RPRXRoyalty Pharma plc - Class A28.69-923.32%
SLNOSoleno Therapeutics Inc29.02-932.73%
ASNDAscendis Pharma A/S30.09-963.44%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1188.06%
APLSApellis Pharmaceuticals Inc39.02-1219.89%
BMRNBiomarin Pharmaceutical Inc42.21-1311.46%
KRYSKrystal Biotech Inc45.34-1401.34%
ONCBeiGene Ltd69.54-2095.78%
PHARPharming Group N.V.75.03-2253.20%
TECHBio-Techne Corp101.96-3026.16%
VCELVericel Corp109.92-3254.69%
ALNYAlnylam Pharmaceuticals Inc117.96-3485.54%
GMABGenmab140.29-4126.28%
TLXTelix Pharmaceuticals Ltd162.15-4753.71%
CORTCorcept Therapeutics Inc212.86-6208.91%